1019 related articles for article (PubMed ID: 18375295)
21. Predictors of early mortality after transjugular intrahepatic portosystemic shunt creation for the treatment of refractory ascites.
Harrod-Kim P; Saad WE; Waldman D
J Vasc Interv Radiol; 2006 Oct; 17(10):1605-10. PubMed ID: 17057001
[TBL] [Abstract][Full Text] [Related]
22. Transjugular intrahepatic portosystemic shunt.
Ochs A
Dig Dis; 2005; 23(1):56-64. PubMed ID: 15920326
[TBL] [Abstract][Full Text] [Related]
23. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.
Ochs A; Rössle M; Haag K; Hauenstein KH; Deibert P; Siegerstetter V; Huonker M; Langer M; Blum HE
N Engl J Med; 1995 May; 332(18):1192-7. PubMed ID: 7700312
[TBL] [Abstract][Full Text] [Related]
24. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?
Chung HH; Razavi MK; Sze DY; Frisoli JK; Kee ST; Dake MD; Hellinger JC; Kang BC
J Gastroenterol Hepatol; 2008 Jan; 23(1):95-101. PubMed ID: 18171347
[TBL] [Abstract][Full Text] [Related]
25. Surgical shunts and TIPS for variceal decompression in the 1990s.
Henderson JM; Nagle A; Curtas S; Geisinger M; Barnes D
Surgery; 2000 Oct; 128(4):540-7. PubMed ID: 11015086
[TBL] [Abstract][Full Text] [Related]
26. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.
Rössle M; Ochs A; Gülberg V; Siegerstetter V; Holl J; Deibert P; Olschewski M; Reiser M; Gerbes AL
N Engl J Med; 2000 Jun; 342(23):1701-7. PubMed ID: 10841872
[TBL] [Abstract][Full Text] [Related]
27. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests.
Baron A; Gulberg V; Sauter G; Waggershauser T; Reiser M; Gerbes AL
Hepatogastroenterology; 1998; 45(24):2315-21. PubMed ID: 9951915
[TBL] [Abstract][Full Text] [Related]
28. [Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension].
Astrup LB; Solvig J; Cwikiel W
Ugeskr Laeger; 1998 Mar; 160(11):1627-32. PubMed ID: 9522655
[TBL] [Abstract][Full Text] [Related]
29. Concomitant hepatic encephalopathy and refractory ascites: successful treatment with staged embolization of two large portosystemic shunts and transjugular intrahepatic portosystemic shunt placement.
Smith JC; Black MD; Mendler MH
J Vasc Interv Radiol; 2007 Nov; 18(11):1441-6. PubMed ID: 18003997
[TBL] [Abstract][Full Text] [Related]
30. Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt.
Russo MW; Jacques PF; Mauro M; Odell P; Brown RS
Liver Transpl; 2002 Mar; 8(3):271-7. PubMed ID: 11910573
[TBL] [Abstract][Full Text] [Related]
31. Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality.
Russo MW; Sood A; Jacobson IM; Brown RS
Am J Gastroenterol; 2003 Nov; 98(11):2521-7. PubMed ID: 14638358
[TBL] [Abstract][Full Text] [Related]
32. Ectopic varices in the gastrointestinal tract: short- and long-term outcomes of percutaneous therapy.
Macedo TA; Andrews JC; Kamath PS
Cardiovasc Intervent Radiol; 2005; 28(2):178-84. PubMed ID: 15719183
[TBL] [Abstract][Full Text] [Related]
33. Elective transjugular intrahepatic portosystemic shunt creation for portal decompression in the immediate pretransplantation period in adult living related liver transplant recipient candidates: preliminary results.
Saad WE; Saad NE; Davies MG; Bozorgdadeh A; Orloff MS; Patel NC; Abt PL; Lee DE; Sahler LG; Kitanosono T; Sasson T; Waldman DL
J Vasc Interv Radiol; 2006 Jun; 17(6):995-1002. PubMed ID: 16778233
[TBL] [Abstract][Full Text] [Related]
34. Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery.
Kim JJ; Dasika NL; Yu E; Fontana RJ
J Clin Gastroenterol; 2009 Jul; 43(6):574-9. PubMed ID: 19169145
[TBL] [Abstract][Full Text] [Related]
35. [Experience with the transjugular intrahepatic portocaval shunt].
Dagenais M; Pomier Layrargues G; Dufresne MP; Roy A; Fenyves D; Lapointe R
Ann Chir; 1994; 48(8):671-8. PubMed ID: 7872613
[TBL] [Abstract][Full Text] [Related]
36. Transjugular intrahepatic portosystemic shunt as a form of treatment for portal hypertension: indications and contraindications.
Brown RS; Lake JR
Adv Intern Med; 1997; 42():485-504. PubMed ID: 9048128
[TBL] [Abstract][Full Text] [Related]
37. Transjugular intrahepatic portosystemic shunts: an update.
Rosado B; Kamath PS
Liver Transpl; 2003 Mar; 9(3):207-17. PubMed ID: 12619016
[TBL] [Abstract][Full Text] [Related]
38. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.
Barrio J; Ripoll C; Bañares R; Echenagusia A; Catalina MV; Camúñez F; Simó G; Santos L
Eur J Radiol; 2005 Jul; 55(1):120-4. PubMed ID: 15950109
[TBL] [Abstract][Full Text] [Related]
39. [Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension].
François E; García-Pagán JC; Bru C; Feu F; Gilabert R; Escorsell A; Bosch J; Rodés J
Gastroenterol Hepatol; 1997 Jan; 20(1):1-4. PubMed ID: 9072189
[TBL] [Abstract][Full Text] [Related]
40. A case-controlled study of the safety and efficacy of transjugular intrahepatic portosystemic shunts after liver transplantation.
King A; Masterton G; Gunson B; Olliff S; Redhead D; Mangat K; Oniscu G; Hayes P; Tripathi D
Liver Transpl; 2011 Jul; 17(7):771-8. PubMed ID: 21714062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
